MedPath

Forhypo

Brand Name: Forhypo

Generic Name: Levothyroxine (as sodium)

Active
Registration Number

DRP-7271-03

Dosage Form

Tablet

Issuance Date

March 1, 2024

Expiry Date

May 20, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength100 mcg
PackagingAmber Glass Bottle x 100's / (Box of 1's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Thyroid Hormone Replacement
A
Application
CLIDP Conversion
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Levothyroxine (as sodium)Active
Monograph: levothyroxine (as sodium)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform